Trials / Unknown
UnknownNCT06288854
Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer with Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial
Efficacy of Olanzapine on Weight Gain in Women with Advanced Stage Gynecologic Cancer Receiving Paclitaxel and Carboplatin Combination Chemotherapy : a Double Blind, Placebo-controlled Randomized Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Department of Medical Services Ministry of Public Health of Thailand · Other Government
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
* Efficacy of olanzapine on weight gain in advanced stage gynecologic cancer * Proprotion of pateints in advanced stage gynecologic cancer who recieving paclitaxel and carboplatin chemotherapy gain weight on olanzapine or placebo
Detailed description
-Proprotion of pateints in advanced stage gynecologic cancer who recieving paclitaxel and carboplatin chemotherapy gain weight on olanzapine or placebo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | weight gain each group | weight gain after 12 Weeks |
Timeline
- Start date
- 2024-04-03
- Primary completion
- 2025-03-31
- Completion
- 2025-06-30
- First posted
- 2024-03-01
- Last updated
- 2024-11-21
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT06288854. Inclusion in this directory is not an endorsement.